当前位置:首页 - 行情中心 - 广济药业(000952) - 财务分析 - 现金流量表

广济药业

(000952)

  

流通市值:25.56亿  总市值:25.76亿
流通股本:3.44亿   总股本:3.47亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金469,573,025.71303,361,830.08152,662,820.51906,178,631.73
  收到的税费返还17,569,623.0716,850,632.052,817,563.3259,360,408.69
  收到其他与经营活动有关的现金16,937,174.317,258,553.178,695,872.7983,581,707.02
  经营活动现金流入小计504,079,823.09327,471,015.3164,176,256.621,049,120,747.44
  购买商品、接受劳务支付的现金273,002,990.07174,916,815.190,403,742.22706,053,107.36
  支付给职工以及为职工支付的现金100,547,667.9270,565,852.6239,317,241.58171,648,380.14
  支付的各项税费20,082,458.1514,272,779.118,549,952.425,741,480.21
  支付其他与经营活动有关的现金62,803,799.8842,452,967.3426,489,964.66145,022,422.33
  经营活动现金流出小计456,436,916.02302,208,414.17164,760,900.861,048,465,390.04
  经营活动产生的现金流量净额47,642,907.0725,262,601.13-584,644.24655,357.4
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额---2,156,281.78
  处置子公司及其他营业单位收到的现金净额55,437,259.444,786,222.0244,786,222.02-
  投资活动现金流入小计55,437,259.444,786,222.0244,786,222.022,156,281.78
  购建固定资产、无形资产和其他长期资产支付的现金32,342,774.5423,676,518.817,527,217.15154,931,562.81
  投资活动现金流出小计32,342,774.5423,676,518.817,527,217.15154,931,562.81
  投资活动产生的现金流量净额23,094,484.8621,109,703.2137,259,004.87-152,775,281.03
三、筹资活动产生的现金流量:
  吸收投资收到的现金---2,000,000
  其中:子公司吸收少数股东投资收到的现金---2,000,000
  取得借款收到的现金558,338,210.76486,661,000360,940,000766,306,480
  收到其他与筹资活动有关的现金-250,000,000--
  筹资活动现金流入小计558,338,210.76736,661,000360,940,000768,306,480
  偿还债务支付的现金622,756,521.74531,444,065.85271,061,400.06660,488,581.5
  分配股利、利润或偿付利息支付的现金38,436,982.8227,211,085.9611,776,178.250,461,528.51
  支付其他与筹资活动有关的现金22,880,354.7222,348,869-14,513,784
  筹资活动现金流出小计684,073,859.28581,004,020.81282,837,578.26725,463,894.01
  筹资活动产生的现金流量净额-125,735,648.52155,656,979.1978,102,421.7442,842,585.99
四、汇率变动对现金及现金等价物的影响827,636.971,200,572.93407,285.071,211,055.97
五、现金及现金等价物净增加额-54,170,619.62203,229,856.46115,184,067.44-108,066,281.67
  加:期初现金及现金等价物余额307,177,265.18307,177,265.18307,177,265.18415,243,546.85
  期末现金及现金等价物余额253,006,645.56510,407,121.64422,361,332.62307,177,265.18
补充资料:
  净利润--82,303,764.28--315,134,061.79
  资产减值准备-2,058,122.98-31,810,540.68
  固定资产和投资性房地产折旧-77,224,568.28-157,953,771.85
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-77,224,568.28-157,953,771.85
  无形资产摊销-3,183,536.08-6,246,765.6
  长期待摊费用摊销-930,919.4-1,918,005.13
  处置固定资产、无形资产和其他长期资产的损失---2,402,290.22
  固定资产报废损失---1,737,915.53
  财务费用-26,434,422.46-61,976,137.73
  投资损失---27,920,916.28
  递延所得税-554,342.67--5,040,709.69
  其中:递延所得税资产减少-617,056.75--4,852,869.68
    递延所得税负债增加--62,714.08--187,840.01
  存货的减少--35,562,029.33--14,164,374.96
  经营性应收项目的减少--70,643,992.61-156,170,677.51
  经营性应付项目的增加-112,570,932.59--114,201,913.22
  其他--9,522,282.92-119,517.52
  现金的期末余额-510,407,121.64-307,177,265.18
  减:现金的期初余额-307,177,265.18-415,243,546.85
  现金及现金等价物的净增加额-203,229,856.46--108,066,281.67
公告日期2025-10-272025-08-292025-04-282025-04-28
审计意见(境内)带强调事项段的无保留意见
TOP↑